Skip to content
Clinical Trials – home

Rheumatic disorder Diagnostics

4 / 5 trials open to patients7 countries

In short

Understanding how rheumatic disorders are diagnosed is the first step toward managing these complex conditions that affect millions worldwide. Whether you're experiencing persistent joint pain or have been referred to a specialist, knowing what to expect from diagnostic testing can ease anxiety and help you become an active partner in your care journey.

Key points

  • Morning joint stiffness lasting more than 45 minutes is a key warning sign that should prompt you to seek medical evaluation for possible rheumatic disease
  • Seeing a rheumatologist within three months of symptom onset can significantly decrease the likelihood of permanent joint and organ damage
  • More than 200 different conditions fall under the umbrella of rheumatic diseases, making specialized expertise crucial for accurate diagnosis
  • MRI scans and ultrasound can detect joint inflammation and damage before it becomes visible on X-rays, enabling earlier diagnosis and treatment
  • Not everyone with rheumatoid arthritis tests positive for rheumatoid factor or anti-CCP antibodies, which is why diagnosis requires multiple sources of information
  • The diagnostic process may take weeks or months due to the complexity of distinguishing between numerous rheumatic conditions
  • Clinical trials often require more comprehensive diagnostic testing and more frequent monitoring than standard clinical care
  • Elevated inflammation markers like C-reactive protein and erythrocyte sedimentation rate help doctors track disease activity and treatment effectiveness over time

Introduction: When to Seek Diagnostic Testing

If you've been experiencing ongoing joint pain, stiffness, or swelling, it's important to understand when these symptoms warrant a visit to your doctor. Rheumatic disorders are a group of more than 200 conditions that typically affect the joints, muscles, bones, ligaments, and tendons, though some can impact internal organs as well. Because symptoms can be general and not always easily noticeable, these conditions are notoriously difficult to recognize on your own.

You should consider seeking medical evaluation if you notice certain warning signs. Common symptoms that suggest you might need diagnostic testing include joint pain, soreness, and tenderness in multiple areas of your body. Inflammation, which appears as swelling, redness, and warmth in a joint or affected area, is another key indicator. Many people with rheumatic conditions also experience joint stiffness that's particularly troublesome in the morning or after sitting for long periods. This stiffness often lasts for 45 minutes or longer after you wake up. Other symptoms that shouldn't be ignored include persistent fatigue, unexplained fever, and weight loss.

The pattern of your symptoms matters too. If you notice that your joints feel better after light activity but worse after strenuous exercise, or if they feel worse during stormy or humid weather, these are clues that point toward a rheumatic condition. It's especially important to pay attention if you're experiencing pain and stiffness in the same joints on both sides of your body, as this symmetrical pattern is characteristic of certain rheumatic diseases like rheumatoid arthritis.

If your regular doctor suspects you have a rheumatic disease based on your symptoms, they will likely refer you to a rheumatologist—a doctor who has specialized training and years of experience in diagnosing and treating these conditions. This specialist will be better equipped to distinguish between the many different types of rheumatic disorders and create an appropriate treatment plan for your specific situation.

Classic Diagnostic Methods

Diagnosing rheumatic diseases can be challenging, especially in the early stages when symptoms may resemble those of other common conditions. Your healthcare provider will use a combination of approaches to reach an accurate diagnosis and understand the severity of your condition. This comprehensive evaluation helps distinguish one rheumatic disease from another and rules out other possible causes of your symptoms.

Medical History and Physical Examination

The diagnostic process always begins with a thorough review of your medical history. Your rheumatologist will ask detailed questions about your presenting symptoms, when they started, how they've changed over time, and what makes them better or worse. They'll also want to know about other health conditions you may have, medications you're taking, your family health history, and whether you smoke or have been exposed to certain environmental factors. This conversation is crucial because risk factors like genetics, smoking, obesity, certain infections, and childhood trauma have all been linked to increased risk of rheumatic diseases.

During the physical examination, your healthcare professional will carefully check your joints for signs of disease. They'll look for swelling, redness, and warmth, and they'll feel your joints to assess tenderness. Your doctor will also check your reflexes and muscle strength to understand how the condition might be affecting your body beyond just the joints. They may squeeze your hands or feet to check for pain or tenderness, another common sign of rheumatic disease.

Blood Tests

Blood tests play a central role in diagnosing rheumatic disorders. These laboratory tests can reveal important information about inflammation levels in your body and help identify specific markers associated with different rheumatic diseases. People with rheumatoid arthritis, for example, often have an elevated erythrocyte sedimentation rate (ESR), also called sed rate, or C-reactive protein (CRP) level, which indicates higher levels of inflammation in the body.

Other blood tests look for specific antibodies—proteins that your immune system produces. Two particularly important tests for rheumatoid arthritis are rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies. The presence of these antibodies can help confirm a diagnosis and may provide clues about how aggressive your disease might be. However, it's important to understand that not everyone with a rheumatic disease will test positive for these markers, and sometimes people without disease can test positive, which is why your doctor considers multiple factors when making a diagnosis.

Because many rheumatic medications can affect your blood cells and liver function, you'll likely need regular blood tests even after diagnosis. These ongoing tests help your healthcare team monitor for any potential side effects of treatment and ensure your medicines are working safely.

Imaging Tests

Imaging tests allow your doctor to see inside your body and assess the condition of your joints, bones, and surrounding tissues. Different imaging techniques provide different types of information, and your doctor may order several types to get a complete picture.

X-rays are commonly used to track rheumatoid arthritis and other rheumatic diseases in your joints over time. In the early stages of disease, X-rays might not show destructive changes in your bones yet, but as the condition progresses, they can reveal damage to cartilage, bone erosion, and joint deformities. X-rays provide a baseline that your doctor can compare with future images to see if the disease is progressing or if treatment is working.

MRI scans (Magnetic Resonance Imaging) and ultrasound tests can provide more detailed information than X-rays. These tests are particularly helpful for diagnosing rheumatic diseases and assessing how severe the condition is. MRI uses magnets and radio waves to create detailed images of your body's soft tissues, including the synovium (the tissue lining your joints), cartilage, tendons, and ligaments. Ultrasound uses sound waves to create real-time pictures and can detect inflammation and damage that might not be visible on X-rays.

Other imaging tests that might be used include CT scans (Computed Tomography), which create detailed three-dimensional images of your body, and bone scans, which can identify areas of increased bone activity that might indicate inflammation or damage.

Additional Diagnostic Procedures

In some cases, your doctor might recommend additional procedures to gather more information. A biopsy, which involves removing a small sample of tissue for examination under a microscope, might be performed to diagnose certain rheumatic conditions or rule out other diseases. The specific type of biopsy depends on which part of your body is affected.

Because rheumatic diseases can be difficult to diagnose—with more than 200 possible conditions to consider—it's important to remain patient throughout the diagnostic process. Diagnosis might not happen right away, and you may need multiple tests over time. The key is to communicate openly with your rheumatologist about your current symptoms and report any new or worsening problems as they arise.

Diagnostics for Clinical Trial Qualification

When researchers conduct clinical trials to test new treatments for rheumatic diseases, they use specific diagnostic tests and criteria to determine which patients can participate. These qualification standards help ensure that the study results are meaningful and that participants are likely to benefit from the experimental treatment being tested. Understanding these requirements can be helpful if you're considering participating in a clinical trial.

Clinical trials typically require participants to have a confirmed diagnosis of the specific rheumatic disease being studied. This means you'll need to undergo the same types of diagnostic tests used in standard medical practice—including medical history review, physical examination, blood tests, and imaging studies. However, clinical trials often have more stringent requirements than routine clinical care. For example, a trial might require specific blood test results showing certain levels of inflammation or the presence of particular antibodies.

Many trials for rheumatoid arthritis use a disease activity score (DAS) to measure how active your disease is at the time of enrollment and throughout the study. This score combines information from physical examination (number of swollen and tender joints), blood tests (inflammation markers), and your own assessment of how you're feeling. Depending on the trial, you might need to have a certain level of disease activity to qualify—for instance, moderate to high disease activity—because researchers want to see if the new treatment can reduce that activity.

Imaging tests are often required as part of clinical trial screening. X-rays, MRI scans, or ultrasound images taken before you enter the study serve as a baseline. Researchers compare these initial images with follow-up images taken during and after the trial to measure whether the experimental treatment is preventing or slowing joint damage. Some trials specifically look for participants who have evidence of joint damage on imaging, while others might focus on people with early disease before significant damage has occurred.

Blood tests used for clinical trial qualification may go beyond the standard diagnostic tests. Researchers might measure specific proteins, inflammatory markers, or genetic factors that help predict whether you're likely to respond to the treatment being studied. These specialized tests aren't always part of routine clinical care but are important for research purposes. You might also need tests to check your overall health, including liver function, kidney function, and blood cell counts, to ensure it's safe for you to receive the experimental treatment.

Before enrolling in a clinical trial, you'll undergo a comprehensive screening process that may include all the diagnostic tests mentioned above. This screening ensures that you meet all the inclusion criteria and don't have any conditions that would exclude you from participation. The screening process also establishes baseline measurements that researchers will compare with results obtained throughout the trial to assess the treatment's effectiveness.

Throughout the clinical trial, you'll continue to undergo regular diagnostic testing—often more frequently than you would in standard care. These repeated tests help researchers monitor your disease activity, track any changes in your joints or overall health, and watch for any side effects of the experimental treatment. While this means more medical appointments and tests, it also means you'll be closely monitored by a team of healthcare professionals throughout your participation in the study.

Did you know?

  1. Rheumatoid arthritis can develop at any age, with specific names for different age groups: "young-onset RA" affects people between 16 and 40, while "later-onset RA" describes disease starting after age 60.[6]
  2. More than two-thirds of people with diagnosed rheumatic conditions are under 65 years old, and approximately 300,000 affected individuals are children, challenging the myth that these diseases only affect the elderly.[7]
  3. While diagnostics influence approximately 70% of healthcare decisions, only 3-5% of healthcare budgets go to diagnostic services, showing a significant gap between importance and investment.[29]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Rheumatic disorder

Recruiting trials first

See all 5 trials →
Quick filters

5 clinical trials in this condition

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amlodipine
  • Sponsor:Instituto De Investigacion Marques De Valdecilla
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Sint Maartenskliniek
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Centre Hospitalier Universitaire De Toulouse
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Isala Klinieken Stichting
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
  • Sponsor:Boehringer Ingelheim Espana S.A.
See all 5 trials →filters applied: condition = Rheumatic disorder

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).